Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study

Abstract OBJECTIVE The main objective of this study was to evaluate non-inferiority of office mean systolic blood pressure (BP) reduction efficacy and superiority of 24-hour ambulatory central BP reduction efficacy between losartan combined with fixed dose amlodipine (L/A group) and dose up-titrated hydrochlorothiazide (L/H group) according to office BP. METHODS We conducted a prospective, randomized, double-blind multicenter trial in 231 patients with hypertensive (mean age = 59.2 ± 12.2 years). Patients received losartan 50 mg monotherapy for 4 weeks, followed by additional use of amlodipine 5 mg or hydrochlorothiazide 12.5 mg for 20 weeks after randomization. The patients who did not achieve the BP goal after 4 weeks’ randomization received an increased dose of 100 mg/5 mg for the L/A group and 100 mg/25 mg for L/H group, respectively. The 24-hour ambulatory central BP was measured at baseline and after 20 weeks’ treatment. RESULTS Office mean systolic BP reduction of L/A group was not inferior to L/H group after 4 weeks’ treatment (–17.6 ± 13.3 vs. –14.4 ± 12.6 mm Hg, P = 0.0863) and was not significantly different after 20 weeks’ treatment. (–15.7 ± 14.0 vs. –14.7 ± 15.1 mm Hg, P = 0.6130) The 24-hour ambulatory central systolic BP was significantly more reduced in the L/A group compared with that in the L/H group after 20 weeks’ treatment (–9.37 ± 10.67 vs. –6.28 ± 10.50 mm Hg, P = 0.0407). The 24-hour ambulatory central systolic BP at the completion of the study and its reduction magnitude were independently associated with reductions in aortic pulse wave velocity, pulse pressure, and wave reflection magnitude. CONCLUSION Office systolic BP reduction with L/A was not inferior to L/H after 4 week’s treatment. The combination of losartan and amlodipine was more favorable in 24-hour ambulatory central hemodynamics beyond BP-lowering efficacy than the combination of losartan and hydrochlorothiazide, regardless of office BP. CLINICAL TRIALS REGISTRATION NCT02294539

[1]  José R. Banegas,et al.  Relationship between Clinic and Ambulatory Blood‐Pressure Measurements and Mortality , 2018, The New England journal of medicine.

[2]  Y. Ahn,et al.  Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized , 2017, Clinical Hypertension.

[3]  M. Abrahamowicz,et al.  Comparison of the Effect of Thiazide Diuretics and Other Antihypertensive Drugs on Central Blood Pressure: Cross‐Sectional Analysis Among Nondiabetic Patients , 2015, Journal of clinical hypertension.

[4]  C. Stefanadis,et al.  Non-invasive 24 hour ambulatory monitoring of aortic wave reflection and arterial stiffness by a novel oscillometric device: the first feasibility and reproducibility study. , 2013, International journal of cardiology.

[5]  H. Schunkert,et al.  Central hemodynamics and arterial stiffness during the finals of the world cup soccer championship 2010. , 2013, International journal of cardiology.

[6]  Siegfried Wassertheurer,et al.  Oscillometric estimation of aortic pulse wave velocity: comparison with intra-aortic catheter measurements , 2013, Blood pressure monitoring.

[7]  B. Williams,et al.  Novel Description of the 24-Hour Circadian Rhythms of Brachial Versus Central Aortic Blood Pressure and the Impact of Blood Pressure Treatment in a Randomized Controlled Clinical Trial: The Ambulatory Central Aortic Pressure (AmCAP) Study , 2013, Hypertension.

[8]  R. Kronmal,et al.  Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). , 2012, Journal of the American College of Cardiology.

[9]  J. Staessen,et al.  24-h ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study , 2012, Hypertension Research.

[10]  Petros Sfikakis,et al.  Feasibility and reproducibility of noninvasive 24-h ambulatory aortic blood pressure monitoring with a brachial cuff-based oscillometric device. , 2012, American journal of hypertension.

[11]  Siegfried Wassertheurer,et al.  Assessment of central haemomodynamics from a brachial cuff in a community setting , 2012, BMC Cardiovascular Disorders.

[12]  W. Zidek,et al.  Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device , 2012, Blood pressure monitoring.

[13]  B. Westerhof,et al.  Wave transmission and reflection of waves "The myth is in their use" , 2012 .

[14]  Siegfried Wassertheurer,et al.  Validation of a Brachial Cuff-Based Method for Estimating Central Systolic Blood Pressure , 2011, Hypertension.

[15]  Y. Ahn,et al.  Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study , 2011, BMC Research Notes.

[16]  E. Lakatta,et al.  Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities , 2011, Journal of hypertension.

[17]  H. Hirose,et al.  Effects of Losartan/Hydrochlorothiazide Treatment, After Change from ARB at Usual Dosage, on Blood Pressure and Various Metabolic Parameters Including High-Molecular Weight Adiponectin in Japanese Male Hypertensive Subjects , 2011, Clinical and experimental hypertension.

[18]  Christodoulos Stefanadis,et al.  Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. , 2010, European heart journal.

[19]  W. Zidek,et al.  Validation of the mobil-O-Graph: 24 h-blood pressure measurement device , 2010, Blood pressure monitoring.

[20]  G. Grassi,et al.  Central blood pressure: getting to the heart of the matter. , 2010, Journal of hypertension.

[21]  K. Kario,et al.  Differential Effects Between a Calcium Channel Blocker and a Diuretic When Used in Combination With Angiotensin II Receptor Blocker on Central Aortic Pressure in Hypertensive Patients , 2009, Hypertension.

[22]  D. Levy,et al.  Single Versus Combined Blood Pressure Components and Risk for Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.

[23]  J. Cohn,et al.  The Arterial System in Human Hypertension , 2007 .

[24]  Richard B. Devereux,et al.  Central Pressure More Strongly Relates to Vascular Disease and Outcome Than Does Brachial Pressure: The Strong Heart Study , 2007, Hypertension.

[25]  G. Mancia,et al.  Central blood pressure measurements and antihypertensive therapy: a consensus document. , 2007, Hypertension.

[26]  Azra Mahmud.  Reducing arterial stiffness and wave reflection – Quest for the Holy Grail? , 2007 .

[27]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[28]  S. Laurent,et al.  Brachial Pressure–Independent Reduction in Carotid Stiffness After Long-Term Angiotensin-Converting Enzyme Inhibition in Diabetic Hypertensives , 2006, Hypertension.

[29]  Christopher M Reid,et al.  Brachial Blood Pressure But Not Carotid Arterial Waveforms Predict Cardiovascular Events in Elderly Female Hypertensives , 2006, Hypertension.

[30]  Alice Stanton,et al.  Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.

[31]  Albert Hofman,et al.  Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study , 2006, Circulation.

[32]  Tine Willum Hansen,et al.  Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population , 2006, Circulation.

[33]  Alice Stanton,et al.  Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study , 2005, Hypertension.

[34]  E. Lakatta,et al.  Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults , 2005, Circulation.

[35]  A. Mendez,et al.  Aortic Pressure Augmentation Predicts Adverse Cardiovascular Events in Patients With Established Coronary Artery Disease , 2005, Hypertension.

[36]  Roberto Sega,et al.  Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study , 2005, Circulation.

[37]  Tine Willum Hansen,et al.  Ambulatory Blood Pressure and Mortality: A Population-Based Study , 2005, Hypertension.

[38]  Yutaka Imai,et al.  Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality: The Ohasama Study , 2005, Hypertension.

[39]  N. Hollenberg.  Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. , 2004, Current hypertension reports.

[40]  S. Priori,et al.  2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2004, Heart Drug.

[41]  Trefor Owen Morgan,et al.  Effect of different antihypertensive drug classes on central aortic pressure. , 2004, American journal of hypertension.

[42]  Peter W de Leeuw,et al.  Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. , 2003, The New England journal of medicine.

[43]  D. Webb,et al.  Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[44]  A. Mitchell,et al.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. , 2002, JAMA.

[45]  S. Laurent,et al.  Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients: A Longitudinal Study , 2002, Hypertension.

[46]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[47]  J. Feely,et al.  Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension , 2000, Journal of Human Hypertension.

[48]  B. Davis,et al.  Isolated systolic hypertension : prognostic information provided by pulse pressure. , 1999, Hypertension.

[49]  Gianfranco Parati,et al.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .

[50]  P Segers,et al.  Use of pulse pressure method for estimating total arterial compliance in vivo. , 1999, American journal of physiology. Heart and circulatory physiology.

[51]  G Mancia,et al.  Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. , 1998, Journal of the American College of Cardiology.

[52]  R. Carretta.  McDonaldʼs Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles , 1998 .

[53]  Yves Lecarpentier,et al.  Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans. , 1998, American journal of physiology. Heart and circulatory physiology.

[54]  W. Nichols,et al.  McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles , 1998 .

[55]  L A Moyé,et al.  Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. , 1997, Circulation.

[56]  W. Nichols.  McDonald's Blood Flow in Arteries , 1996 .

[57]  Eric Vicaut,et al.  Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition , 1996, Journal of hypertension.

[58]  R. Reneman,et al.  The influence of perindopril and the diuretic combination amiloride + hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients , 1995, Journal of hypertension.

[59]  M. Safar,et al.  Comparison of effects of felodipine versus hydrochlorothiazide on arterial diameter and pulse-wave velocity in essential hypertension. , 1993, The American journal of cardiology.

[60]  M. Safar,et al.  Influence of diuretics on brachial artery diameter and distensibility in hypertensive patients , 1990, Fundamental & clinical pharmacology.

[61]  M. Safar,et al.  Salt and water retention and calcium blockade in uremia. , 1990, Circulation.

[62]  M. Safar,et al.  Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. , 1988, Circulation.

[63]  M. Safar,et al.  Comparative Effects of Captopril and Isosorbide Dinitrate on the Arterial Wall of Hypertensive Human Brachial Arteries , 1986, Journal of cardiovascular pharmacology.

[64]  S. Laurent,et al.  An indirect approach for the study of the elastic modulus of the brachial artery in patients with essential hypertension. , 1986, Cardiovascular research.

[65]  J. Robertson.  HANDBOOK OF HYPERTENSION , 1984, The Lancet.

[66]  T. Zelinka,et al.  Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension , 2016, Journal of Human Hypertension.

[67]  M. Safar,et al.  Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. , 1994, Hypertension.

[68]  A. Zanchetti,et al.  European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension , 2003 .